⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

November 1, 2005The Journal of Clinical Endocrinology & Metabolism

Prognostic Impact of Serum Calcitonin and Carcinoembryonic Antigen Doubling-Times in Patients with Medullary Thyroid Carcinoma

View Full Paper

Ask AI

Bookmark

Share

Abstract

Calcitonin DT may be superior to initial clinical staging and among the most powerful prognostic indicators in MTC.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Barbet et al. (2005) studied this question.

synapsesocial.com/papers/69da2667a6045d71bfa3c402 https://doi.org/10.1210/jc.2005-0044

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Long term follow-up of patients with medullary carcinoma of the thyroidCohort Study · 1997 · 161 citations
2Diagnostic and Prognostic Values of Carcinoembryonic Antigen in Medullary Carcinoma of the Thyroid*Prognostic Study · 1984 · 111 citations
3Medullary thyroid carcinomaPrognostic Study · 2000 · 686 citations
4Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patientsPrognostic Study · 1998 · 576 citations
5Medullary Thyroid Carcinoma: Prognosis of Familial<i>Versus</i>Sporadic Disease and the Role of Radiotherapy*Prognostic Study · 1988 · 168 citations